Update on the use of hydroxyurea therapy in sickle cell disease
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 18, 2014
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Adult (MeSH)
- Anemia, Sickle Cell (MeSH)
- Anti-Inflammatory Agents, Non-Steroidal (MeSH)
- Antisickling Agents (MeSH)
- Child, Preschool (MeSH)
- Female (MeSH)
- Hospitalization (MeSH)
- Humans (MeSH)
- Hydroxyurea (MeSH)
- Immunology (Science Metrix)
- Male (MeSH)
- Observational Studies as Topic (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Treatment Outcome (MeSH)
- Young Adult (MeSH)
- beta-Thalassemia (MeSH)
published in
- Blood Journal